These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31438878)
41. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Xu W; Liu CF; Yan L; Li JJ; Wang LJ; Qi Y; Cheng RB; Xiong XY Virol J; 2012 Jan; 9():8. PubMed ID: 22230340 [TBL] [Abstract][Full Text] [Related]
42. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754 [TBL] [Abstract][Full Text] [Related]
43. Optimizing the use of intravenous magnesium sulfate for acute asthma treatment in children. Liu X; Yu T; Rower JE; Campbell SC; Sherwin CM; Johnson MD Pediatr Pulmonol; 2016 Dec; 51(12):1414-1421. PubMed ID: 27218606 [TBL] [Abstract][Full Text] [Related]
44. Risk factors for death in children with severe hand, foot, and mouth disease in Hunan, China. Long L; Gao LD; Hu SX; Luo KW; Chen ZH; Ronsmans C; Zhou DL; Lan YJ Infect Dis (Lond); 2016 Oct; 48(10):744-8. PubMed ID: 27195893 [TBL] [Abstract][Full Text] [Related]
45. [Effects of ribavirin aerosol on viral exclusion of patients with hand-foot-mouth disease]. Pan S; Qian J; Gong X; Zhou Y Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1563-6. PubMed ID: 25146745 [TBL] [Abstract][Full Text] [Related]
46. Intravenous magnesium sulfate in acute severe asthma. Boonyavorakul C; Thakkinstian A; Charoenpan P Respirology; 2000 Sep; 5(3):221-5. PubMed ID: 11022983 [TBL] [Abstract][Full Text] [Related]
47. Usefulness of low-level laser for control of painful stomatitis in patients with hand-foot-and-mouth disease. Toida M; Watanabe F; Goto K; Shibata T J Clin Laser Med Surg; 2003 Dec; 21(6):363-7. PubMed ID: 14709221 [TBL] [Abstract][Full Text] [Related]
48. Regional-level risk factors for severe hand-foot-and-mouth disease: an ecological study from mainland China. Pan Q; Liu F; Zhang J; Zhao X; Hu Y; Fan C; Yang F; Chang Z; Xiao X Environ Health Prev Med; 2021 Jan; 26(1):4. PubMed ID: 33419405 [TBL] [Abstract][Full Text] [Related]
49. Lack of efficacy of nebulized magnesium sulfate in treating adult asthma: A meta-analysis of randomized controlled trials. Ling ZG; Wu YB; Kong JL; Tang ZM; Liu W; Chen YQ Pulm Pharmacol Ther; 2016 Dec; 41():40-47. PubMed ID: 27651324 [TBL] [Abstract][Full Text] [Related]
50. [Risk factors of heart and lung failure in children with severe hand, foot and mouth disease and treatment experience]. Liu ZQ; Li XH; Wang HQ; Luo Y; Mu DZ Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):589-92. PubMed ID: 22898279 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of combined liver function and high-sensitivity C-reactive protein measurement in children with hand-foot-mouth disease. Han FX; Gao JH; Gai JH Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706779 [TBL] [Abstract][Full Text] [Related]
52. Risk factors for severe hand foot mouth disease in Singapore: a case control study. Chew SP; Chong SL; Barbier S; Matthew A; Lee JH; Chan YH BMC Infect Dis; 2015 Oct; 15():486. PubMed ID: 26520791 [TBL] [Abstract][Full Text] [Related]
53. Use of magnesium sulphate in severe persistent pulmonary hypertension of the newborn. Chandran S; Haqueb ME; Wickramasinghe HT; Wint Z J Trop Pediatr; 2004 Aug; 50(4):219-23. PubMed ID: 15357561 [TBL] [Abstract][Full Text] [Related]
54. [Efficacy and safety of ribavirin aerosol in children with hand-foot-mouth disease]. Zhang HP; Wang L; Qian JH; Cai K; Chen YH; Zhang QL; Yu HJ Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):272-6. PubMed ID: 24661520 [TBL] [Abstract][Full Text] [Related]
55. The use of magnesium sulphate infusions in the management of very severe tetanus. James MF; Manson ED Intensive Care Med; 1985; 11(1):5-12. PubMed ID: 3968303 [TBL] [Abstract][Full Text] [Related]
56. Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection. Huang X; Zhang X; Wang F; Wei H; Ma H; Sui M; Lu J; Wang H; Dumler JS; Sheng G; Xu B PLoS One; 2016; 11(2):e0148907. PubMed ID: 26882102 [TBL] [Abstract][Full Text] [Related]
57. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013. Huang Y; Zhou Y; Lu H; Yang H; Feng Q; Dai Y; Chen L; Yu S; Yao X; Zhang H; Jiang M; Wang Y; Han N; Hu G; He Y J Med Virol; 2015 Sep; 87(9):1471-9. PubMed ID: 25951788 [TBL] [Abstract][Full Text] [Related]
58. Reduning injection for fever, rash, and ulcers in children with mild hand, foot, and mouth disease: a randomized controlled clinical study. Zhang G; Zhao J; He L; Yan S; Zhuo Z; Zheng H; Mu Y; Li S; Zhang X; Huang J; Li X; Liu J; Wan H; Wei C; Xiao W J Tradit Chin Med; 2013 Dec; 33(6):733-42. PubMed ID: 24660604 [TBL] [Abstract][Full Text] [Related]
59. [Application of esmolol in severe hand, foot, and mouth disease]. Zhu L; Qi BX; Fang DH; Qi GJ; Gao K; Hu BL Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):44-48. PubMed ID: 28100321 [TBL] [Abstract][Full Text] [Related]
60. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation. Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]